Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death

Fig. 4

Rats receiving empagliflozin are less predisposed to severe post-IR ventricular tachyarrhythmias. A Mean VT durations for rats with or without empagliflozin. n = 13–15. Rats without VT were indicated as 0 s duration. B The longest episode of VT duration (LVT) for rats with or without empagliflozin. n = 13–15. C The onset time of first VT episode after cardiac reperfusion for rats with or without empagliflozin. n = 13–15

Back to article page